Early combination therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Kumar A, Zarychanski R, Light B, et al: Early combination therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis. Crit Care Med 2010; 38:1773-1785.
Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group
D'Agostino RB Jr: Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med 1998; 17:2265-2281.
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units
Brun-Buisson C, Donon F, Cartlet J, et al: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. J Am Med Assoc 1995; 274:968-974.
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
Second International Study of Infarct Survival (ISIS-2) Collaborative Group
Second International Study of Infarct Survival (ISIS-2) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2:349-360.